Skip to content
lifestyle.floredechampagne.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AbbVie
Allergan Aesthetics Announces U.S. FDA Acceptance of Supplemental Biologics License Application for BOTOX® Cosmetic for Masseter Muscle Prominence
August 5, 2026
SkinMedica® Deepens Commitment to Regenerative Science with Continued Investment in Research and Development
July 14, 2026
AbbVie to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
June 2, 2026
AbbVie Announces European Commission Authorization of Expanded Label for VENCLYXTO® (venetoclax) to Include Additional Combinations in Previously Untreated Chronic Lymphocytic Leukemia
May 29, 2026